Citations

Clear

16280 citation(s) found for "Yu, David".

Primary Cutaneous T Cell Lymphoma of the External Genitalia
Clemens, A., Thiel, David D. , Wu, Kevin J.

Mayo Clinic

Journal of Urology | December 20, 2010 | Volume: 185 | Issue: 2 | Pages: 687-688

10.1016/j.juro.2010.11.013 | PMID 21172707 Get It

Second brain death examination may negatively affect organ donation
Lustbader, Dana, O’Hara, David L., MacLean, Leah K. , Tajik, Waheed, Ying, Alexander W. , Berg, E.W., Goldstein, M. C., Wijdicks, Eelco F. M.

Mayo Clinic

Neurology | December 16, 2010 | Volume: 76 | Issue: 2 | Pages: 119-124

10.1212/wnl.0b013e3182061b0c | PMID 21172836 Get It

Collateral Circulation in Symptomatic Intracranial Atherosclerosis
Liebeskind, David S. , Cotsonis, George, Saver, Jeffrey L. , Cloft, Harry J. , Chimowitz, Marc I. , (WASID), Investigators For the Warfarin—Aspirin Symptomatic Intracranial Disease, Liebeskind, David S. , Lynn, Michael , (WASID), Investigators For the Warfarin—Aspirin Symptomatic Intracranial Disease, Saver, Jeffrey

Mayo Clinic

Journal of Cerebral Blood Flow & Metabolism | December 15, 2010 | Volume: 31 | Issue: 5 | Pages: 1293-1301

10.1038/jcbfm.2010.224 | PMID 21157476 Get It

Collateral circulation in intracranial atherosclerosis has never been systematically characterized. We investigated collaterals in a multicenter trial of symptomatic intracranial atherosclerotic disease. Baseline angiography was reviewed for information on collaterals in stenoses of the internal carotid, middle cerebral, vertebral, and basilar arteries. A battery of angiographic scales was utilized to evaluate lesion site, arterial patency, antegrade flow, downstream territorial perfusion, and collateral circulation, blinded to all other data. Collateral circulation was adequately available for analysis in 287/569 (50%) subjects with proximal arterial stenoses ranging from 50% to 99%. Extent of collaterals was absent or none in 69%, slow or minimal in 10%, more rapid, yet incomplete perfusion of territory in 7%, complete but delayed perfusion in 11%, and rapid, complete collateral perfusion in 4%. Extent of collateral flow correlated with percentage of stenosis ( P < 0.0001), with more severe stenoses exhibiting greater compensation via collaterals. Overall, collateral grade increased with diminished antegrade flow across the lesion (thrombolysis in myocardial ischemia) and resultant downstream perfusion (thrombolysis in cerebral infarction) (both P<0.001). Our findings provide the initial detailed description of collaterals across a variety of stenoses, suggesting that collateral perfusion is a pivotal component in pathophysiology of intracranial atherosclerosis and implicating the need for further evaluation in ongoing studies.
Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?
Whitwell, Jennifer L. , Jack, Clifford R. , Parisi, Joseph E., Senjem, Matthew L. , Rademakers, Rosa , Petersen, Ronald C. , Dickson, Dennis W. , Josephs, Keith A. , Knopman, David S. , Boeve, Bradley F. , Baker, Matthew , Dickson, Dennis W , Jack, Clifford R , Senjem, Matthew L

Mayo Clinic

Neurology | December 14, 2010 | Volume: 75 | Issue: 24 | Pages: 2212-2220

10.1212/wnl.0b013e31820203c2 | PMID 21172844 Get It

Effect of Emphysema on Lung Cancer Risk in Smokers: A Computed Tomography–Based Assessment
Li, Yan , Swensen, Stephen J., Karabekmez, Leman Günbey , Marks, Randolph S., Stoddard, Shawn M., Jiang, Ruoxiang , Worra, Joel B., Zhang, Fang , Midthun, David E. , Song, Yong , Andrade, Mariza de , Yang, Ping

Mayo Clinic

Cancer Prevention Research | December 1, 2010 | Volume: 4 | Issue: 1 | Pages: 43-50

10.1158/1940-6207.capr-10-0151 | PMID 21119049 Get It

Abstract The contribution of emphysema to lung cancer risk has been recognized, but the effect size needs to be further defined. In this study, 565 primary lung cancer cases were enrolled though a prospective lung cancer cohort at Mayo Clinic, and 450 controls were smokers participating in a lung cancer screening study in the same institution using spiral computed tomography (CT). Cases and controls were frequency matched on age, gender, race, smoking status, and residential region. CT imaging using standard protocol at the time of lung cancer diagnosis (case) or during the study (control) was assessed for emphysema by visual scoring CT analysis as a percentage of lung tissue destroyed. The clinical definition of emphysema was the diagnosis recorded in the medical documentation. Using multiple logistic regression models, emphysema (≥5% on CT) was found to be associated with a 3.8-fold increased lung cancer risk in Caucasians, with higher risk in subgroups of younger (&lt;65 years old, OR = 4.64), heavy smokers (≥40 pack-years, OR = 4.46), and small-cell lung cancer (OR = 5.62). When using &gt;0% or ≥10% emphysema on CT, lung cancer risk was 2.79-fold or 3.33-fold higher than controls. Compared with CT evaluation (using criterion ≥5%), the sensitivity, specificity, positive and negative predictive values, and the accuracy of the clinical diagnosis for emphysema in controls were 19%, 98%, 73%, 84%, and 83%, respectively. These results imply that an accurate evaluation of emphysema could help reliably identify individuals at greater risk of lung cancer among smokers. Cancer Prev Res; 4(1); 43–50. ©2010 AACR.
Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up
Saxon, Leslie A. , Hayes, David L. , Gilliam, F. Roosevelt, Heidenreich, Paul A. , Seth, Milan, Meyer, Timothy E. , Jones, Paul W. , Boehmer, John , Day, John

Mayo Clinic

Circulation | November 23, 2010 | Volume: 122 | Issue: 23 | Pages: 2359-2367

10.1161/circulationaha.110.960633 | PMID 21098452 Get It

Background— Outcome data for patients receiving implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy–defibrillator (CRT-D) devices treated outside of clinical trials are lacking. No clinical trial has evaluated mortality after device implantation or after shock therapy in large numbers of patients with implanted devices that regularly transmit device data over a network. Methods and Results— Survival status in patients implanted with ICD and CRT devices across the United States from a single manufacturer was assessed. Outcomes were compared between patients followed in device clinic settings and those who regularly transmit remote data collected from the device an average of 4 times monthly. Shock delivery and electrogram analysis could be ascertained from patients followed on the network, enabling survival after ICD shock to be evaluated. One- and 5-year survival rates in 185 778 patients after ICD implantation were 92% and 68% and were 88% and 54% for CRT-D device recipients. In 8228 patients implanted with CRT-only devices, survival was 82% and 48% at 1 and 5 years, respectively. For the 69 556 ICD and CRT-D patients receiving remote follow-up on the network, 1- and 5-year survival rates were higher compared with those in the 116 222 patients who received device follow-up in device clinics only (50% reduction; P <0.0001). There were no differences between patients followed on or off the remote network for the characteristics of age, gender, implanted device year or type, and economic or educational status. Shock therapy was associated with subsequent mortality risk for both ICD and CRT-D recipients. Conclusions— Survival after ICD and CRT-D implantation in patients treated in naturalistic practice compares favorably with survival rates observed in clinical trials. Remote follow-up of device data is associated with excellent survival, but arrhythmias that result in device therapy in this population are associated with a higher mortality risk compared with patients who do not require shock therapy.
Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients With Chemotherapy-Associated Anemia
Steensma, David P. , Sloan, Jeff A. , Dakhil, Shaker R. , Dalton, Robert J., Kahanic, Stephen P., Prager, Diane J., Stella, Philip J., Rowland, Kendrith M. , Novotny, Paul J. , Loprinzi, Charles L. , Steensma, David P

Mayo Clinic

Journal of Clinical Oncology | November 23, 2010 | Volume: 29 | Issue: 1 | Pages: 97-105

10.1200/jco.2010.30.3644 | PMID 21098317 Get It

Purpose Functional iron deficiency may impair response to erythropoiesis-stimulating agents (ESAs) in iron-replete patients with chemotherapy-associated anemia (CAA). This study evaluated whether coadministration of parenteral iron improves ESA efficacy in patients with CAA. Patients and Methods This prospective, multicenter, randomized trial enrolled 502 patients with hemoglobin (Hb) less than 11 g/dL who were undergoing chemotherapy for nonmyeloid malignancies. All patients received darbepoetin alfa once every 3 weeks and were randomly assigned to receive either ferric gluconate 187.5 mg intravenously (IV) every 3 weeks, oral daily ferrous sulfate 325 mg, or oral placebo for 16 weeks. Results There was no difference in the erythropoietic response rate (ie, proportion of patients achieving Hb ≥12 g/dL or Hb increase ≥ 2 g/dL from baseline): 69.5% (95% CI, 61.9% to 76.5%) of IV iron-treated patients achieved an erythropoietic response compared with 66.9% (95% CI, 59.1% to 74.0%) who received oral iron and 65.0% (95% CI, 57.2% to 72.3%) who received oral placebo (P = .75). There were also no differences in the proportion of patients requiring red cell transfusions, changes in quality of life, or the dose of darbepoetin administered. Adverse events (AEs) tended to be more common in the IV iron arm: grade 3 or higher AEs occurred in 54% (95% CI, 46% to 61%) of patients receiving IV iron compared with 44% (95% CI, 36% to 52%) who received oral iron and 46% (95% CI, 38% to 54%) who received oral placebo (P = .16). Conclusion In patients with CAA, addition of IV ferric gluconate to darbepoetin failed to provide additional benefit compared with oral iron or oral placebo.
Percutaneous Cryoablation of Anterior Renal Masses: Technique, Efficacy, and Safety
Schmit, Grant D. , Atwell, Thomas D. , Leibovich, Bradley C. , Callstrom, Matthew R. , Woodrum, David A. , Charboneau, J. William, Kurup, A. Nicholas

Mayo Clinic

American Journal of Roentgenology | November 22, 2010 | Volume: 195 | Issue: 6 | Pages: 1418-1422

10.2214/ajr.09.3530 | PMID 21098204 Get It

Understanding and Finding Mentorship: A Review for Junior Faculty
Carey, Elise C. , Weissman, David E.

Mayo Clinic

Journal of Palliative Medicine | November 19, 2010 | Volume: 13 | Issue: 11 | Pages: 1373-1379

10.1089/jpm.2010.0091 | PMID 21091022 Get It